Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure

Trial Profile

Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Sirolimus (Primary) ; Calcineurin inhibitors
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 21 Feb 2008 Status change from recruiting to in progress.
    • 26 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top